- Home
- WVE vs JFR Comparison
WVE vs JFR Comparison
Compare WVE & JFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVE
- JFR
- Stock Information
- Founded
- WVE 2012
- JFR 2004
- Country
- WVE Singapore
- JFR United States
- Employees
- WVE N/A
- JFR N/A
- Industry
- WVE Biotechnology: Pharmaceutical Preparations
- JFR Trusts Except Educational Religious and Charitable
- Sector
- WVE Health Care
- JFR Finance
- Exchange
- WVE Nasdaq
- JFR Nasdaq
- Market Cap
- WVE 915.6M
- JFR 1.1B
- IPO Year
- WVE 2015
- JFR N/A
- Fundamental
- Price
- WVE $6.97
- JFR $8.40
- Analyst Decision
- WVE Strong Buy
- JFR
- Analyst Count
- WVE 17
- JFR 0
- Target Price
- WVE $19.94
- JFR N/A
- AVG Volume (30 Days)
- WVE 2.4M
- JFR 621.7K
- Earning Date
- WVE 11-11-2025
- JFR 01-01-0001
- Dividend Yield
- WVE N/A
- JFR 11.31%
- EPS Growth
- WVE N/A
- JFR N/A
- EPS
- WVE N/A
- JFR N/A
- Revenue
- WVE $93,946,000.00
- JFR N/A
- Revenue This Year
- WVE N/A
- JFR N/A
- Revenue Next Year
- WVE $10.02
- JFR N/A
- P/E Ratio
- WVE N/A
- JFR N/A
- Revenue Growth
- WVE N/A
- JFR N/A
- 52 Week Low
- WVE $5.28
- JFR $7.61
- 52 Week High
- WVE $16.74
- JFR $8.82
- Technical
- Relative Strength Index (RSI)
- WVE 29.71
- JFR 44.67
- Support Level
- WVE $7.12
- JFR $8.38
- Resistance Level
- WVE $7.76
- JFR $8.45
- Average True Range (ATR)
- WVE 0.51
- JFR 0.05
- MACD
- WVE -0.32
- JFR -0.00
- Stochastic Oscillator
- WVE 0.57
- JFR 38.89
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
About JFR Nuveen Floating Rate Income Fund
Nuveen Floating Rate Income Fund is a diversified closed-end management investment company. Its investment objective is to achieve a high level of current income, consistent with the preservation of capital. It invests in adjustable-rate U.S. dollar-denominated secured Senior Loans.